Abstract:CYP2C9 is a major P450 2C enzyme, which hydroxylates about 16% of drugs that are in current clinical use and contributes to the metabolism of a number of clinically important substrate drugs such as warfarin. Ethnic differences in the genetic variation of CYP2C9 have been reported, and might be related to the frequencies of adverse reactions to drugs metabolized by CYP2C9 in different ethnic groups. In the present study, ethnic differences in the CYP2C9*2 and CYP2C9*3 allele distribution in Japanese and Israeli populations were evaluated using a newly developed oligonucleotide based DNA array (OligoArray). The population studied consisted of 147 Japanese and 388 Israeli donors (100 Ashkenazi Jews, 99 Yemenite Jews, 100 Moroccan Jews and 89 Libyan Jews). The CYP2C9*2 [Arg144Cys (416 C>T), exon 3] and CYP2C9*3 [Ile359Leu (1061 A>C), exon 7] genotypes were determined using an OligoArray. The accuracy of genotyping by the OligoArray was verified by the fluorescent dyeterminator cycle sequencing method. A Hardy–Weinberg test indicated equilibrium (v<3.84 is Hardy–Weinberg) in all populations. The CYP2C9*2 genotype (CC/CT+TT) was absent in Japanese (1 /0) (OR 0.02), and its frequency was significant in Libyan Jews (0.697 / 0.303) (OR 2.13; 95% CI 1.07–4.24) compared with Ashkenazi Jews (0.83 /0.17), Yemenite Jews (0.899 /0.101), and Moroccan Jews (0.81 /0.19). The frequencies of CYP2C9*3 genotype (AA/AC+CC) was significantly lower in Japanese (0.986 /0.014) (OR 0.08), and was higher in Libyan Jews (0.652 /0.348) (OR 3.03; 95% CI 1.5–6.1) and Moroccan Jews (0.77 /0.23) (OR 1.69; 95% CI 0.62–3.48) compared with those in Ashkenazi Jews (0.85 /0.15) and Yemenite Jews (0.849 /0.151). Thus, the CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) variants were rare in the Japanese population, and showed different frequencies in the four Jewish ethnic groups examined. D 2005 Elsevier Inc. All rights reserved.

Ascertainment of pesticide exposures of migrant and seasonal farmworker children: findings from focus groups.

Simultaneous genotyping of three major Se enzyme inactivating SNPs of FUT2 based on a triplex probe-based fluorescence melting-curve analysis

High‐resolution melting analysis for detection of fusion allele of FUT2

Simultaneous Genotyping of Three SNVs, rs5471, rs5472, and rs2000999 Involved in Serum Haptoglobin Levels by Fluorescent Probe‐Based Melting Curve Analysis

Detection of Cytochrome P450 2D6 Allele CYP2D6*6 by Using Allele-specific Amplification

Molecular Cloning of a Human Genomic Region Containing the H Blood Group α(1,2)Fucosyltransferase Gene and Two H Locus-related DNA Restriction Fragments

Identification of 14 new alleles at the fucosyltransferase 1, 2, and 3 loci in Styrian blood donors, Austria

FUT1 variants responsible for Bombay or para-Bombay phenotypes in a database

Genotyping of cytochrome P450 2D6 enzyme deficient alleles CYP2D6A and CYP2D6B by one-step ASA analysis

Detection of cytochrome P4502D6 allele CYP2D6C with allele-specific amplification

The potentially curable prostate cancer patient and the pathways leading to diagnosis and treatment

Television violence and its sponsors.

High fidelity SNP genotyping using sequence-specific primer elongation and fluorescence correlation spectroscopy

Variants in Linkage Status at D5S818 Detected by Multiple STR Kits Comparison and Sanger Sequencing.

A single multiplex PCR and Single Nucleotide Extension Assay for the detection of common Thanatophoric dysplasia I and II mutations.

An Automated Fluorescent Single Strand Conformation Polymorphism Technique for High Throughput Mutation Screening.

Ethnic differences in CYP 2 C 9 * 2 ( Arg 144 Cys ) and CYP 2 C 9 * 3 ( Ile 359 Leu ) genotypes in Japanese and Israeli populations

Polymorphic gene conferring susceptibility to insulin-dependent diabetes mellitus typed by ps-resolved FRET on nonamplified genomic DNA

Ultra-specific discrimination of single-nucleotide mutations using sequestration-assisted molecular beacons.

Detection and allele-frequencies of the 833T>C, 844ins68 and a novel mutation in the cystathionine beta-synthase gene

Inverse Shifting-PCR Modified by Capillary Electrophoresis for Detecting F8 int22h and int1h Inversions in Severe Hemophilia A Patients and Probable Carriers